98 related articles for article (PubMed ID: 2459193)
21. T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity.
Young DB; Lamb JR
Immunology; 1986 Oct; 59(2):167-71. PubMed ID: 2429917
[TBL] [Abstract][Full Text] [Related]
22. Influenza virus hemagglutinin-binding T cells in delayed hypersensitivity induced in mice.
Ochałek T; Porwit-Bóbr Z
Acta Microbiol Pol; 1985; 34(2):155-8. PubMed ID: 2412403
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the antigen specificity of influenza haemagglutinin-immune human T lymphocyte clones: identification of an immunodominant region for T cells.
Lamb JR; Green N
Immunology; 1983 Dec; 50(4):659-66. PubMed ID: 6197356
[TBL] [Abstract][Full Text] [Related]
24. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.
Sweetser MT; Morrison LA; Braciale VL; Braciale TJ
Nature; 1989 Nov; 342(6246):180-2. PubMed ID: 2478887
[TBL] [Abstract][Full Text] [Related]
25. Influenza virus M2 protein ion channel activity is not required to maintain the equine-1 hemagglutinin in its native form in infected cells.
Takeuchi K; Shaughnessy MA; Lamb RA
Virology; 1994 Aug; 202(2):1007-11. PubMed ID: 7518161
[TBL] [Abstract][Full Text] [Related]
26. Human T cell clones present antigen.
Hewitt CR; Feldmann M
J Immunol; 1989 Jul; 143(2):762-9. PubMed ID: 2472452
[TBL] [Abstract][Full Text] [Related]
27. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody.
Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W
Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422
[TBL] [Abstract][Full Text] [Related]
28. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.
Saikh KU; Martin JD; Nishikawa AH; Dillon SB
Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546
[TBL] [Abstract][Full Text] [Related]
29. Role of receptor-binding activity of the viral hemagglutinin molecule in the presentation of influenza virus antigens to helper T cells.
Eisenlohr LC; Gerhard W; Hackett CJ
J Virol; 1987 May; 61(5):1375-83. PubMed ID: 2952806
[TBL] [Abstract][Full Text] [Related]
30. Antigenic determinants of influenza virus hemagglutinin. XI. Conformational changes detected by monoclonal antibodies.
Jackson DC; Nestorowicz A
Virology; 1985 Aug; 145(1):72-83. PubMed ID: 2409671
[TBL] [Abstract][Full Text] [Related]
31. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.
Eisenlohr LC; Hackett CJ
J Exp Med; 1989 Mar; 169(3):921-31. PubMed ID: 2784481
[TBL] [Abstract][Full Text] [Related]
32. Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.
Kittlesen DJ; Brown LR; Braciale VL; Sambrook JP; Gething MJ; Braciale TJ
J Exp Med; 1993 Apr; 177(4):1021-30. PubMed ID: 8096235
[TBL] [Abstract][Full Text] [Related]
33. Immunogenic structure of the influenza virus hemagglutinin.
Green N; Alexander H; Olson A; Alexander S; Shinnick TM; Sutcliffe JG; Lerner RA
Cell; 1982 Mar; 28(3):477-87. PubMed ID: 6176330
[TBL] [Abstract][Full Text] [Related]
34. T-lymphocyte recognition of a membrane glycoprotein.
Braciale TJ; Sweetser MT; Brown LR; Braciale VL
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():477-85. PubMed ID: 2639766
[No Abstract] [Full Text] [Related]
35. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.
Galili U; Repik PM; Anaraki F; Mozdzanowska K; Washko G; Gerhard W
Vaccine; 1996 Mar; 14(4):321-8. PubMed ID: 8744560
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis.
Yewdell JW; Gerhard W; Bachi T
J Virol; 1983 Oct; 48(1):239-48. PubMed ID: 6193286
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.
Bächi T; Gerhard W; Yewdell JW
J Virol; 1985 Aug; 55(2):307-13. PubMed ID: 2410628
[TBL] [Abstract][Full Text] [Related]
38. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment.
Puri A; Booy FP; Doms RW; White JM; Blumenthal R
J Virol; 1990 Aug; 64(8):3824-32. PubMed ID: 2196382
[TBL] [Abstract][Full Text] [Related]
39. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.
Daniels RS; Douglas AR; Skehel JJ; Wiley DC
J Gen Virol; 1983 Aug; 64 (Pt 8)():1657-62. PubMed ID: 6192202
[TBL] [Abstract][Full Text] [Related]
40. Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.
Kostolansky F; Russ G; Mucha V; Styk B
Arch Virol; 1988; 101(1-2):13-24. PubMed ID: 2458086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
